Reuket
9.3K posts

Reuket
@reuket
J’aime les chats, les sciences et rire de l’espèce humaine et tout particulièrement de moi même.














Switzerland just took a noticeably different path on mRNA vaccines. A political motion submitted in early March by SVP National Councillor Rémi Wyssmann, backed by the Action Alliance Free Switzerland, calls for excluding mRNA-based vaccines from standard approval. The core argument: current clinical studies do not sufficiently meet the stricter scientific standards required for routine authorisation. They want robust long-term safety data evaluated first. This comes after Swissmedic had recorded over 16,000 suspected adverse reaction reports for COVID-19 vaccines (with thousands classified as serious in their updates). While Europe and much of the world continue heavy investment in expanding mRNA technology for flu, cancer, RSV, malaria and beyond — including new startups from former BioNTech executives — Switzerland is essentially pressing pause and demanding higher evidentiary standards for this still-relatively-new platform. It’s one of the clearest counter-movements we’ve seen so far. Makes you wonder what it signals when a highly regulated country chooses caution over momentum. Anyone else paying attention to how different nations are reassessing mRNA platforms post-COVID? What stands out to you?



















